Cambridge Heart HearTwave
This article was originally published in The Gray Sheet
Executive SummaryShipments are expected in the third quarter of the firm's test to predict life threatening heart rhythm disturbances and sudden death. FDA's 510(k) clearance of the test, which measures Microvolt T-wave Alternans, is announced June 14
You may also be interested in...
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.